Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 3,894 INR
Change Today -106.05 / -2.65%
Volume 5.8K
SANL On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

sanofi india ltd (SANL) Snapshot

Open
3,975
Previous Close
4,000
Day High
3,977
Day Low
3,860
52 Week High
08/3/15 - 4,581
52 Week Low
09/17/14 - 2,923
Market Cap
89.7B
Average Volume 10 Days
12.1K
EPS TTM
63.00
Shares Outstanding
23.0M
EX-Date
07/29/15
P/E TM
61.8x
Dividend
42.00
Dividend Yield
1.36%
Current Stock Chart for SANOFI INDIA LTD (SANL)

Related News

No related news articles were found.

sanofi india ltd (SANL) Related Businessweek News

No Related Businessweek News Found

sanofi india ltd (SANL) Details

Sanofi India Limited manufactures and sells pharmaceutical products in India and internationally. It provides medicines for the treatment of patients in various therapeutic areas, such as cardiovascular diseases, thrombosis, diabetes, oncology, respiratory system, central nervous system, dermatology, analgesics, anti-infectives, bone and joint, gastrointestinal disorders, and consumer healthcare. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was founded in 1956 and is based in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

3,448 Employees
Last Reported Date: 03/9/15
Founded in 1956

sanofi india ltd (SANL) Top Compensated Officers

Managing Director, Vice President of South As...
Total Annual Compensation: 8.9M
Compensation as of Fiscal Year 2014.

sanofi india ltd (SANL) Key Developments

Sanofi India Limited Announces Executive Changes

Sanofi India Limited that Ms. Virginie Simone Jeanine Verrechia (Ms. Virginie Boucinha) who has been the Chief Financial Officer (CFO) from July 01, 2012 and Director of the company from July 25, 2012 has stepped down as the CFO as she has taken up a senior position with the Sanofi Group in France. She continues to be a non-executive director of the company. Mr. Lionel Guerin who was CFO o Sanofi Poland from June 2011 has been appointed as CFO of the company from July 24, 2015. Mr. Guerin was CFO of one of Saint-Gobain Group's affiliates in Poland between 2000 and 2003.

Sanofi India Limited Announces Executive Changes

Sanofi India Limited announced that the following changes will take place in the board of directors: Mr. J. M. Georges has resigned as director with effect from the close of business hours on July 20, 2015 due to internal re-origination. Mr. M. G, Rao, who was Alternate to Mr. J. M. Georges, has consequently ceased to be Alternate Director. Mr. Patrick Chocat, Vice President, Strategy and Manufacturing System, Individual Affairs has been appointed a director with effect from July 21, 2015 in place of Mr. Georges. Mr. Jerome Silvestre, Sr. Vice President, Intercontinental Region, Global Operations has been appointed as director with effect from July 21, 2015 in place of Mr. A. Ortoli who had resigned as director earlier this year, following his resignation.

Sanofi India Ltd Declares Interim Dividend for the Financial Year Ending December 31, 2015, Payable on August 12, 2015

Sanofi India Ltd. has informed that the Board of Directors of the company at its meeting held on July 21, 2015 has declared an interim dividend of INR 18 per equity share of INR 10 for the financial year ending December 31, 2015. The interim dividend will be paid on August 12, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SANL:IN 3,893.65 INR -106.05

SANL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 5,214 INR +103.85
Cadila Healthcare Ltd 1,813 INR -52.80
Medivation Inc $88.23 USD +0.49
Pfizer Ltd/India 2,314 INR -26.05
Piramal Enterprises Ltd 877.35 INR -8.45
View Industry Companies
 

Industry Analysis

SANL

Industry Average

Valuation SANL Industry Range
Price/Earnings 42.9x
Price/Sales 4.2x
Price/Book 5.5x
Price/Cash Flow 22.3x
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI INDIA LTD, please visit www.sanofiindialtd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.